Tony McCue started stumbling and "dropping things" — now he's unable to speak or eat, relying on a feeding tube ...
Massachusetts General Hospital coordinated the first four platform trials within the HEALEY ALS platform to evaluate ...
NEW research has shown that pridopidine, a sigma-1 receptor agonist, does not exhibit a significant impact on the progression of amyotrophic lateral sclerosis (ALS) over a 24-week period.
A new study published in the recent issue of Journal of American Medical Association found that the usage of verdiperstat, a ...
News Medical on MSN4d
Study of familial ALS in Egypt reveals that genetic variations may contribute to disease progressionAmyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease characterized by the progressive degeneration ...
Medpage Today on MSN5d
Two Investigational Treatments for ALS Show Glimmer of HopeThe first four treatments in a platform trial for amyotrophic lateral sclerosis (ALS) failed to reach key endpoints in phase ...
Oxysterols are a class of molecules derived from cholesterol via oxidation or as byproducts of cholesterol synthesis. Despite ...
Patients increasingly complain that it is difficult to win approval from health insurance companies for certain types of ...
ALS is a progressive neurodegenerative disease that currently has no cure. Commonly known as Lou Gehrig’s disease, ALS ...
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with few treatment options. Since 2018, the Sean M.
LOS ANGELES, CA / ACCESS Newswire / February 22, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback